<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0484-7903</journal-id>
<journal-title><![CDATA[Revista mexicana de anestesiología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. mex. anestesiol.]]></abbrev-journal-title>
<issn>0484-7903</issn>
<publisher>
<publisher-name><![CDATA[Colegio Mexicano de Anestesiología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0484-79032019000100045</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Recomendaciones basadas en evidencia para el manejo del dolor oncológico (revisión de la literatura)]]></article-title>
<article-title xml:lang="en"><![CDATA[Evidence-based recommendations for the management of cancer pain (review of the literature)]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[León]]></surname>
<given-names><![CDATA[Marta Ximena]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Santa-Cruz]]></surname>
<given-names><![CDATA[Juan Guillermo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez-Rojas]]></surname>
<given-names><![CDATA[Susan]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ibatá-Bernal]]></surname>
<given-names><![CDATA[Linda]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de La Sabana Facultad de Medicina ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Universitario Fundación Santa Fe de Bogotá Servicio de Cuidados Paliativos ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,MSc Salud Pública NeuroEconomix ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2019</year>
</pub-date>
<volume>42</volume>
<numero>1</numero>
<fpage>45</fpage>
<lpage>55</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0484-79032019000100045&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0484-79032019000100045&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0484-79032019000100045&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Objetivo:  Describir recomendaciones basadas en evidencia para el manejo integral del dolor oncológico.  Metodología:  Revisión temática basada en una búsqueda de guías de práctica clínica para el manejo integral del dolor oncológico, desde el 2012 al 2017. De las referencias incluidas, se recolectó información relacionada con la evaluación, clasificación, indicaciones de tratamiento, principios de manejo farmacológico y no farmacológico.  Resultados:  Se incluyeron 12 estudios relacionados con el manejo del dolor oncológico, después de la eliminación de duplicados. Se realizó una síntesis y análisis de aspectos relevantes enfocados en: 1) evaluación del dolor; 2) clasificación del dolor oncológico; 3) principios y metas de manejo del dolor, así como el tratamiento farmacológico y no farmacológico; y 4) seguimiento. Se recomienda que los pacientes con dolor leve (puntaje de 1 a 3) que no hayan sido tratados con opioides previamente, sean tratados con acetaminofén o antiinflamatorios no esteroideos (AINEs). Para pacientes con dolor leve que no responden a analgésicos no opioides y para pacientes con intensidad del dolor mayor o igual a 4, se recomiendan opioides de acción corta.  Conclusión:  El dolor oncológico inadecuadamente tratado constituye un problema de salud pública, por lo que es primordial una adecuada evaluación para asegurar de manera oportuna un manejo efectivo desde el diagnóstico, seguimiento a intervalos regulares y cuando se inicie un nuevo tratamiento.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Objective:  To describe the evidence-based recommendations for the integral management of oncological pain.  Methodology:  Literature review based on a search of clinical practice guidelines for the comprehensive management of oncological pain, from 2012 to 2017. From the included references, it was obtained information related the evaluation, classification, indications of treatment, principles of pharmacological management and not pharmacological.  Results:  We included 12 studies related for the management of oncological pain, after the elimination of duplicates. The synthesis and analysis of relevant aspects focused on 1) pain assessment; 2) classification of oncological pain; 3) principles and goals of pain management, as well as pharmacological and non-pharmacological management; and 4) follow-up. It is recommended that patients with mild pain (score of 1 to 3) who have not been previously treated with opioids, should be treated with acetaminophen or NSAIDs. For patients with mild pain who do not respond to non-opioids and for patients with pain intensity greater than or equal to four, short-acting opioids are recommended.  Conclusion:  Oncological pain inadequately treated constitutes a public health problem, which is why adequate evaluation is essential to ensure proper management from the moment of diagnosis, with follow-up at regular intervals and when a new treatment is initiated, in order to find best balance between efficacy and safety of the interventions, and maximizing functionality and improving the patient&#8217;s quality of life. The management of oncological pain therefore requires a multidisciplinary approach.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Dolor en cáncer]]></kwd>
<kwd lng="es"><![CDATA[manejo del dolor]]></kwd>
<kwd lng="es"><![CDATA[terapéutica]]></kwd>
<kwd lng="es"><![CDATA[guías de práctica clínica como asunto]]></kwd>
<kwd lng="en"><![CDATA[Cancer pain]]></kwd>
<kwd lng="en"><![CDATA[pain management]]></kwd>
<kwd lng="en"><![CDATA[therapeutics]]></kwd>
<kwd lng="en"><![CDATA[practice guidelines as topic]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Merskey]]></surname>
<given-names><![CDATA[HBN]]></given-names>
</name>
</person-group>
<collab>Classification of Chronic Pain</collab>
<source><![CDATA[Descriptions of chronic pain syndromes and definitions of pain terms [Internet]]]></source>
<year>1994</year>
<edition>2</edition>
<publisher-loc><![CDATA[Seattle, WA ]]></publisher-loc>
<publisher-name><![CDATA[IASP Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Swarm]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Abernethy]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Anghelescu]]></surname>
<given-names><![CDATA[DL]]></given-names>
</name>
<name>
<surname><![CDATA[Benedetti]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Buga]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Cleeland]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adult cancer pain]]></article-title>
<source><![CDATA[J Natl Compr Canc Netw]]></source>
<year>2013</year>
<volume>11</volume>
<page-range>992-1022</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<collab>Scottish Intercollegiate Guidelines Network</collab>
<source><![CDATA[SIGN 106 Control of pain in adults with cancer [Internet]]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="">
<collab>Family Practice Oncology Network Guidelines and Protocols Advisory Committee (BC)</collab>
<source><![CDATA[Palliative Care for the Patient with Incurable Cancer or Advanced Disease Part 2: Pain and Symptom Management [Internet]]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ripamonti]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Santini]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Maranzano]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Berti]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Roila]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of cancer pain: ESMO clinical practice guidelines]]></article-title>
<collab>ESMO Guidelines Working Group</collab>
<source><![CDATA[Ann Oncol]]></source>
<year>2012</year>
<volume>23</volume>
<page-range>vii139-54</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yamaguchi]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Shima]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Morita]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Hosoya]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Matoba]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical guideline for pharmacological management of cancer pain: the Japanese Society of Palliative Medicine recommendations]]></article-title>
<source><![CDATA[Jpn J Clin Oncol]]></source>
<year>2013</year>
<volume>43</volume>
<page-range>896-909</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="">
<collab>German Guideline Program in Oncology</collab>
<source><![CDATA[Guideline_Palliative_Care_Short_Version.pdf [Internet]]]></source>
<year>2015</year>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<collab>Cancer Care Ontario</collab>
<source><![CDATA[Cancer-related pain management: a report of evidence-based recommendations to guide practice [Internet]]]></source>
<year>2011</year>
<publisher-name><![CDATA[Cancer Care Ontario]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Butler]]></surname>
<given-names><![CDATA[SF]]></given-names>
</name>
<name>
<surname><![CDATA[Fernandez]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Benoit]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Budman]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
<name>
<surname><![CDATA[Jamison]]></surname>
<given-names><![CDATA[RN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validation of the revised screener and opioid assessment for patients with pain (SOAPP-R)]]></article-title>
<source><![CDATA[J Pain]]></source>
<year>2008</year>
<volume>9</volume>
<page-range>360-72</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Webster]]></surname>
<given-names><![CDATA[LR]]></given-names>
</name>
<name>
<surname><![CDATA[Webster]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool]]></article-title>
<source><![CDATA[Pain Med]]></source>
<year>2005</year>
<volume>6</volume>
<page-range>432-42</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="">
<collab>The National Institute for Health and Care Excellence</collab>
<source><![CDATA[Palliative care for adults: strong opioids for pain relief | Guidance and guidelines | NICE [Internet]]]></source>
<year>2012</year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="">
<collab>Health Service Executive (HSE)/Royal College of Physicians (RCPI) National, Clinical Programme for Palliative Care, Clinical Programme for Palliative Care</collab>
<source><![CDATA[Pharma-Mgmt-Cancer-Pain.pdf [Internet]]]></source>
<year>2015</year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
